NO975321L - Reverse fluorocarbon emulsion mixtures for drug delivery - Google Patents

Reverse fluorocarbon emulsion mixtures for drug delivery

Info

Publication number
NO975321L
NO975321L NO975321A NO975321A NO975321L NO 975321 L NO975321 L NO 975321L NO 975321 A NO975321 A NO 975321A NO 975321 A NO975321 A NO 975321A NO 975321 L NO975321 L NO 975321L
Authority
NO
Norway
Prior art keywords
drug delivery
emulsions
fluorocarbon emulsion
emulsion mixtures
phase
Prior art date
Application number
NO975321A
Other languages
Norwegian (no)
Other versions
NO975321D0 (en
Inventor
Thomas E Tarara
Jeffry G Weers
Leo A Trevino
Alexey Kablanov
Luis A Dellamary
Gina M Hopper
Helen M Ranney
David H Klein
Timothy J Pelura
Original Assignee
Alliance Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharma filed Critical Alliance Pharma
Publication of NO975321D0 publication Critical patent/NO975321D0/en
Publication of NO975321L publication Critical patent/NO975321L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En polar væske-i-perfluor-forbindelsesemulsjon eller -mikroemulsjon for bruk ved avlevering av terapeutiske eller diagnostiske midler.Disse preparater tildannes ved å kombinere en dis-kontinuerlig, vandig fase, en kontinuerlig fluorkarbon-fase og en ikke-fluorert surfaktant.Videre kan de polare væske-i-fluor-forbindelses-emulsjoner benyttes for å danne multippelemulsjoner med en vandig, kontinuerlig fase.Slike emulsjoner og mikroemulsjoner er egnet for administrering av farmasøytiske midler inkludert genetisk materiale.A polar liquid-in-perfluoro compound emulsion or microemulsion for use in the delivery of therapeutic or diagnostic agents. These compositions are formed by combining a discontinuous aqueous phase, a continuous fluorocarbon phase and a non-fluorinated surfactant. the polar liquid-in-fluorine compound emulsions are used to form multiple emulsions with an aqueous, continuous phase. Such emulsions and microemulsions are suitable for the administration of pharmaceuticals including genetic material.

NO975321A 1995-06-07 1997-11-19 Reverse fluorocarbon emulsion mixtures for drug delivery NO975321L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48761295A 1995-06-07 1995-06-07
PCT/US1996/009064 WO1996040057A2 (en) 1995-06-07 1996-06-05 Reverse fluorocarbon emulsion compositions for drug delivery

Publications (2)

Publication Number Publication Date
NO975321D0 NO975321D0 (en) 1997-11-19
NO975321L true NO975321L (en) 1998-01-27

Family

ID=23936452

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975321A NO975321L (en) 1995-06-07 1997-11-19 Reverse fluorocarbon emulsion mixtures for drug delivery

Country Status (11)

Country Link
EP (1) EP0833608A2 (en)
JP (1) JPH11508237A (en)
KR (1) KR19990022354A (en)
CN (1) CN1195981A (en)
AU (1) AU704918B2 (en)
CA (1) CA2222063A1 (en)
HU (1) HUP9900879A2 (en)
IL (1) IL122249A0 (en)
NO (1) NO975321L (en)
PL (1) PL323931A1 (en)
WO (1) WO1996040057A2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1117999A (en) * 1997-10-24 1999-05-17 Alliance Pharmaceutical Corporation Amelioration of ischemic damage using synthetic oxygen carriers
AU1314899A (en) * 1997-11-10 1999-05-31 Sonus Pharmaceuticals, Inc. Emulsions for aerosolization and drug delivery
US6127430A (en) * 1998-12-16 2000-10-03 3M Innovative Properties Company Microemulsions containing water and hydrofluroethers
US6159917A (en) * 1998-12-16 2000-12-12 3M Innovative Properties Company Dry cleaning compositions containing hydrofluoroether
US6375975B1 (en) * 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6271200B1 (en) * 1998-12-21 2001-08-07 Generex Pharmaceuticals Inc. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
US6451286B1 (en) * 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US6294153B1 (en) * 1998-12-21 2001-09-25 Generex Pharmaceuticals, Inc. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
US7087215B2 (en) 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US6312665B1 (en) 1998-12-21 2001-11-06 Generex Pharmaceuticals Incorporated Aerosol formulations for buccal and pulmonary application
US6849263B2 (en) 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
EP1338272A1 (en) * 1998-12-21 2003-08-27 Generex Pharmaceuticals Inc. Aerosol formulations for buccal and pulmonary application comprising chenodeoxycholate or deoxycholate
US7357937B2 (en) 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
GB0307403D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
AU2003903296A0 (en) * 2003-06-30 2003-07-10 Raustech Pty Ltd Chemical compositions of matter
WO2006057429A1 (en) * 2004-11-24 2006-06-01 Nanocarrier Co., Ltd. Method of changing morphology of block copolymer
EP2047910B1 (en) 2006-05-11 2012-01-11 Raindance Technologies, Inc. Microfluidic device and method
FR2903602B1 (en) * 2006-07-12 2012-10-26 Seppic Sa INJECTABLE FORMULATION WITH PROLONGED RELEASE OF ACTIVE INGREDIENTS, PROCESS FOR PREPARING THE SAME
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20110159078A1 (en) * 2008-01-22 2011-06-30 Vapogenix, Inc Volatile Anesthetic Compositions and Methods of Use
EP2123256A1 (en) 2008-05-19 2009-11-25 Ruhr-Universität Bochum Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
EP2315629B1 (en) 2008-07-18 2021-12-15 Bio-Rad Laboratories, Inc. Droplet libraries
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
WO2011100604A2 (en) 2010-02-12 2011-08-18 Raindance Technologies, Inc. Digital analyte analysis
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc Anti-fibroblastic fluorochemical emulsion therapies
US9351943B2 (en) * 2010-07-01 2016-05-31 Matthew T. McLeay Anti-fibroblastic fluorochemical emulsion therapies
US20120135947A1 (en) * 2010-11-29 2012-05-31 Mitsubishi Tanabe Pharma Corporation Oil-in-water emulsion composition containing difluprednate and tobramycin
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
SG10202010626PA (en) * 2011-03-31 2020-11-27 Schaefer Konstanze Perfluorinated compounds for the non-viral transfer of nucleic acids
DE202012013668U1 (en) 2011-06-02 2019-04-18 Raindance Technologies, Inc. enzyme quantification
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
CA2951922C (en) * 2014-06-12 2023-02-28 Evan C. Unger Phospholipid composition and microbubbles and emulsions formed using same
US9699301B1 (en) * 2015-05-31 2017-07-04 Emma Michaela Siritzky Methods, devices and systems supporting driving and studying without distraction
CN109908085B (en) * 2019-04-23 2021-12-03 董红燕 Respiratory tract administration medicine carrier, its preparation method and application in preparing medicine for treating heart disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2720943B1 (en) * 1994-06-09 1996-08-23 Applic Transferts Technolo Stable inverse emulsions with a high concentration of fluorinated compound (s) and their use for the pulmonary administration of medicaments and for the manufacture of multiple emulsions.

Also Published As

Publication number Publication date
PL323931A1 (en) 1998-04-27
WO1996040057A3 (en) 1997-02-20
JPH11508237A (en) 1999-07-21
MX9709561A (en) 1998-10-31
IL122249A0 (en) 1998-04-05
AU704918B2 (en) 1999-05-06
HUP9900879A2 (en) 1999-08-30
HU9900879D0 (en) 1999-05-28
CA2222063A1 (en) 1996-12-19
CN1195981A (en) 1998-10-14
EP0833608A2 (en) 1998-04-08
NO975321D0 (en) 1997-11-19
AU6153796A (en) 1996-12-30
KR19990022354A (en) 1999-03-25
WO1996040057A2 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
NO975321L (en) Reverse fluorocarbon emulsion mixtures for drug delivery
AU643690B2 (en) Injectable multi-phase emulsions
NO992068D0 (en) Microemulsion and process for its preparation
DK0850046T3 (en) Microemulsions for use as vehicle for administration of active compounds
IS4224A (en) A pharmaceutical formulation in the form of a droplet containing a short-acting calcium antidote of the dihydropyridine antidepressant
BRPI0111016B8 (en) Stable, biologically compatible, well tolerated water-in-oil microemulsion and its use
DK0478686T3 (en) Flour and phosphorus-containing amphiphilic molecules with surfactant properties
DE69402297T2 (en) Cosmetic or dermatological powder, process for its preparation and uses
DE69923181D1 (en) TEMPERATURE SENSITIVE LIPOSOMAL FORMULATION
ES2137524T3 (en) REVERSE AND MULTIPLE STABLE FLUOROCARBON EMULSIONS.
AU5377596A (en) Film forming foundation
DE69926843D1 (en) ACTIVE VITAMIN D3 CONTAINING LOTIONS IN THE FORM OF EMULSIONS
WO1999056727A3 (en) Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
RS52388B (en) Acidic insulin preparations with improved stability
AR011428A1 (en) COMPOSITION FOR PERSONAL CLEANING IN THE FORM OF A STABLE WATER EMULSION
MA23344A1 (en) NEW EMULSION COMPOSITIONS
DE69416824D1 (en) POLYPEPTIDES AND PRODUCTS MADE THEREOF, AGENTS EFFECTING HIV
MXPA97007996A (en) Preparation for the transport of an active substance across barriers.
WO2003082222A3 (en) Cosmetic or pharmaceutical low-viscosity (atomizable) o/w emulsions containing phospholipids
FR2740360B1 (en) WATER REDISPERSABLE GRANULES COMPRISING AN ACTIVE MATERIAL IN LIQUID FORM
AU6462396A (en) Vaccine for infectious agents, composition for treating and preventing hiv infections
FR2681247B1 (en) PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION CONTAINING DITHRANOL AND METHOD OF PREPARATION.
CO4180470A1 (en) COSMETIC COMPOSITIONS
SE9402455D0 (en) Bilayer preparations
KR970032883A (en) Compositions for Oral Administration

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application